Device Feasibility and Acceptability to Improve Insomnia in Cancer

Description

Sleep disruption is common among young adult cancer survivors for a variety of reasons. Cognitive behavioral therapy for insomnia (CBT-I) has been shown to improve chronic sleep disorders. This project will test the feasibility and acceptability of a new voice-activated virtual assistant (VAVA) device to deliver CBT-I to improve sleep among young adult cancer survivors with chronic sleep disorders.

Conditions

Cancer, Insomnia Chronic

Talk to us

Study Overview

On this page

Study Details

Study overview

Sleep disruption is common among young adult cancer survivors for a variety of reasons. Cognitive behavioral therapy for insomnia (CBT-I) has been shown to improve chronic sleep disorders. This project will test the feasibility and acceptability of a new voice-activated virtual assistant (VAVA) device to deliver CBT-I to improve sleep among young adult cancer survivors with chronic sleep disorders.

Intervention for Chronic Insufficient Sleep in Young Adult Cancer Survivors

Device Feasibility and Acceptability to Improve Insomnia in Cancer

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

Washington

MedStar Washington Hospital Center, Washington, District of Columbia, United States, 20010

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * age between 18 and 29 years old
  • * history of cancer (any type, any stage)
  • * chronic sleep loss as evidence by self-report of receiving less sleep than recommended for their age by the National Sleep Foundation for \>/= 3 months
  • * must have an internet router in their primary home that they have access to (can add a second router to for the system to work)
  • * acute medical/psychiatric disorder requiring treatment
  • * developmental or congenital disorder
  • * life expectancy \<12 months.

Ages Eligible for Study

18 Years to 39 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Medstar Health Research Institute,

Study Record Dates

2023-12-31